Needle-free Injection System Market Demand, Supply, Growth Factors, Latest Rising Trend and Forecast to 2026
Growth in Needle-free Injection System market
is mainly driven by technological advancements, increasing demand for self-injection
devices, and the rising incidence of chronic diseases. With the rising
geriatric population and the increasing prevalence of chronic diseases, the
patient volume has increased significantly globally.
The needle-free injection system market is projected to
reach USD 272 million by 2026 from USD 124 million in 2021, at a CAGR of 17.0%
from 2020 to 2026.
Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=165815861
On the basis of technology, the needle-free injection system
market can be segmented into jet-based, spring-based, microarray patches and
other injectors. In 2020, the jet-based needle-free injectors segment is
expected to command the largest share of 67.4% of the global needle-free
injection system devices market by technology. This segment is projected to
reach USD 196.9 million by 2026 from USD 71.4 million in 2020, at a CAGR of
18.3% during the forecast period.
Based on the type, the needle-free injection system market
is segmented into liquid-based, powder-based and projectile/depot-based
needle-free injectors. The liquid-based segment accounted for the largest share
of 70.9% of the needle-free injection system market. The large share of this
segment can be attributed to the ability of a liquid jet, which is stronger
enough to penetrate the skin and the underlying fat layer without harming the
skin or the integrity of the drug molecule.
Based on site of delivery, the needle-free injection system
market is segmented into subcutaneous, intramuscular and intradermal. In 2020,
the subcutaneous injectors segment is estimated to account for the largest
share of 48% of the needle-free injection system market by the site of
delivery.
The prominent players in global needle-free injection market
include PharmaJet (US), Portal Instruments (US), Medical International
Technology, Inc (MIT) (US), NuGen Medical Devices (Canada), Crossject SA (US),
and Bioject Medical Technologies (US).
PHARMAJET
PharmaJet held the first position in the needle-free
injection system market in 2020. PharmaJet is a leading provider of needle-free
injectors. The company has developed PharmaJet Needle-free devices that deliver
pharmaceuticals, vaccines, and liquid injectables through the skin,
accomplished by the use of jet injection technology.
Download Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=165815861
North America accounted segment accounted for the largest
share in the needle-free injection system market.
On the basis of region, the needle-free injection system
market is segmented into North America, Europe, Asia Pacific, Latin America,
and the Middle East & Africa. In 2020, North America accounted for the
largest share of 58% of the needle-free injection market, followed by Europe,
the Asia Pacific (APAC), Latin America, and the Middle East & Africa.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Comments
Post a Comment